 | • レポートコード：PMR2006004 • 出版社/出版日：Persistence Market Research / 2020年4月 • レポート形態：英文、PDF、177ページ • 納品方法：Eメール • 産業分類：生命科学 |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、注意欠陥多動性障害（ADHD）治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場状況、市場背景、市場需要分析・予測、薬物種類別（覚醒剤、非興奮剤）分析、年齢別（小児・青年、成人）分析、流通経路別（病院薬局、専門クリニック、電子商取引）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場状況 ・市場背景 ・市場需要分析・予測 ・注意欠陥多動性障害（ADHD）治療の世界市場規模：薬物種類別（覚醒剤、非興奮剤） ・注意欠陥多動性障害（ADHD）治療の世界市場規模：年齢別（小児・青年、成人） ・注意欠陥多動性障害（ADHD）治療の世界市場規模：流通経路別（病院薬局、専門クリニック、電子商取引） ・注意欠陥多動性障害（ADHD）治療の世界市場規模：地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ） ・競争分析 ・仮定 ・調査手法 |
Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market – Scope of the Report
Persistence Market Research (PMR) recently published a study on the global attention-deficit hyperactivity disorder (ADHD) therapeutics market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the ADHD therapeutics market structure. The market study presents exclusive information about how the attention-deficit hyperactivity disorder therapeutics market will grow during the forecast period of 2020-2030.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes market share analysis by region and by product type, which helps in the deep understanding of the market by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the attention-deficit hyperactivity disorder therapeutics market during the forecast period.
The study is relevant for manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macroeconomics factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the attention-deficit hyperactivity disorder therapeutics market. Furthermore, small businesses and new entrants in the ADHD therapeutics market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Key Questions Answered in PMR’s ADHD Therapeutics Market Report
Which regions will continue to remain the most profitable regional markets for ADHD therapeutics market players?
Which factors will induce a change in the demand for ADHD therapeutics during the assessment period?
What are the different opportunities available for emerging players in the attention-deficit hyperactivity disorder therapeutics market?
How are supply-side and demand-side drivers impacting the ADHD therapeutics market?
How will changing trends impact the attention-deficit hyperactivity disorder therapeutics market?
How can market players capture the low-hanging opportunities in the ADHD therapeutics market in developed regions?
Which companies are leading the attention-deficit hyperactivity disorder therapeutics market?
What are the winning strategies of stakeholders in the ADHD therapeutics market to upscale their position in this landscape?
ADHD Therapeutics Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the attention-deficit hyperactivity disorder therapeutics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the attention-deficit hyperactivity disorder therapeutics market study include statistics from government healthcare organizations, medicines journals, research journals, press release, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the attention-deficit hyperactivity disorder therapeutics market, and makes PMR’s projection on the growth prospects of the ADHD therapeutics market more accurate and reliable.
レポート目次1. Executive Summary
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development Trends
4. Market Context
4.1. Value Chain Analysis
4.2. List of Drug Manufacturers & Distributers/Suppliers
4.3. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market – Product Overview
4.4. PEST Analysis
4.5. Key Regulations
4.6. Disease Epidemiology
5. Market Background
5.1. Macro-Economic Factors
5.2. Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunity
6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2014 – 2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2019 – 2029
7.3.1. Stimulants
7.3.1.1. Amphetamine
7.3.1.2. Methylphenidate
7.3.1.3. Dextroamphetamine
7.3.1.4. Dexmethylphenidate
7.3.1.5. Lisdexamfetamine dimesylate
7.3.2. Non-stimulants
7.3.2.1. Atomoxetine
7.3.2.2. Bupropion
7.3.2.3. Guanfacine
7.3.2.4. Clonidine
7.4. Market Attractiveness Analysis By Drug Type
8. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Age Group
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 – 2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Age Group, 2019 – 2029
8.3.1. Paediatric and Adolescent
8.3.2. Adult
8.4. Market Attractiveness Analysis By Age Group
9. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Age Group, 2014 – 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029
9.3.1. Hospital Pharmacies
9.3.2. Speciality Clinics
9.3.3. Retail Pharmacies
9.3.4. e-Commerce
9.4. Market Attractiveness Analysis By Age Group
10. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. MEA
10.4. Market Attractiveness Analysis By Region
11. North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug Type
11.3.3. By Age Group
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug Type
11.4.3. By Age Group
11.4.4. By Distribution Channel
12. Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Drug Type
12.3.3. By Age Group
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug Type
12.4.3. By Age Group
12.4.4. By Distribution Channel
13. Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
13.3.1. By Country
13.3.1.1. U.K.
13.3.1.2. France
13.3.1.3. Germany
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. Rest of Europe
13.3.2. By Drug Type
13.3.3. By Age Group
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug Type
13.4.3. By Age Group
13.4.4. By Distribution Channel
14. Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
14.3.1. By Country
14.3.1.1. Japan
14.3.1.2. China
14.3.1.3. India
14.3.1.4. Australia and New Zealand
14.3.1.5. ASEAN
14.3.1.6. Rest of APAC
14.3.2. By Drug Type
14.3.3. By Age Group
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug Type
14.4.3. By Age Group
14.4.4. By Distribution Channel
15. MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 – 2029
15.3.1. By Country
15.3.1.1. GCC Countries
15.3.1.2. South Africa
15.3.1.3. North Africa
15.3.1.4. Rest of MEA
15.3.2. By Drug Type
15.3.3. By Age Group
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Type
15.4.3. By Age Group
15.4.4. By Distribution Channel
16. Competition Analysis
16.1. Competition Dashboard
16.2. Competition Deep Dive
16.2.1. Pfizer Inc.
16.2.1.1. Overview
16.2.1.2. Product Overview
16.2.1.3. Key Financial
16.2.1.4. Key Developments
16.2.1.5. Analyst Commentary
16.2.2. Eli Lilly and Company
16.2.2.1. Overview
16.2.2.2. Product Overview
16.2.2.3. Key Financial
16.2.2.4. Key Developments
16.2.2.5. Analyst Commentary
16.2.3. Novartis AG
16.2.3.1. Overview
16.2.3.2. Product Overview
16.2.3.3. Key Financial
16.2.3.4. Key Developments
16.2.3.5. Analyst Commentary
16.2.4. GlaxoSmithKline PLC
16.2.4.1. Overview
16.2.4.2. Product Overview
16.2.4.3. Key Financial
16.2.4.4. Key Developments
16.2.4.5. Analyst Commentary
16.2.5. Mallinckrodt Pharmaceuticals
16.2.5.1. Overview
16.2.5.2. Product Overview
16.2.5.3. Key Financial
16.2.5.4. Key Developments
16.2.5.5. Analyst Commentary
16.2.6. Hisamitsu Pharmaceutical Co., Inc.
16.2.6.1. Overview
16.2.6.2. Product Overview
16.2.6.3. Key Financial
16.2.6.4. Key Developments
16.2.6.5. Analyst Commentary
16.2.7. Johnson & Johnson
16.2.7.1. Overview
16.2.7.2. Product Overview
16.2.7.3. Key Financial
16.2.7.4. Key Developments
16.2.7.5. Analyst Commentary
16.2.8. UCB S.A.
16.2.8.1. Overview
16.2.8.2. Product Overview
16.2.8.3. Key Financial
16.2.8.4. Key Developments
16.2.8.5. Analyst Commentary
16.2.9. Purdue Pharma L.P.
16.2.9.1. Overview
16.2.9.2. Product Overview
16.2.9.3. Key Financial
16.2.9.4. Key Developments
16.2.9.5. Analyst Commentary
17. Assumptions and Acronyms Used
18. Research Methodology
List of TablesTable 01: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 02: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Age Group
Table 03: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 04: Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Region
Table 05: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 06: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group
Table 07: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 08: North America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country
Table 09: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 10: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group
Table 11: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 12: Latin America Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country
Table 13: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 14: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group
Table 15: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 16: Europe Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country
Table 17: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 18: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group
Table 19: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 20: Asia Pacific Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country
Table 21: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Drug Type
Table 22: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Age Group
Table 23: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Distribution Channel
Table 24: MEA Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, by Country